First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin
Clinical trial NCT00982111 · COMPLETED
Trial details
- NCT number
- NCT00982111
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-02
- Primary completion
- 2012-11-14
- Enrollment
- 633
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.